Form 4 for MCRB Seres Therapeutics, Inc.
Accepted 2022-10-31 00:00:00 ET · period of report 2022-06-15 · accession 0000899243-22-034577 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-31 | 2022-06-15 | MCRB | Arkowitz David | CFO | M - OptEx | $0.00 | +5,000 | 70.5K | +8% | $0 |
| D | 2022-10-31 | 2022-10-27 | MCRB | Arkowitz David | CFO | A - Grant | $0.00 | +42.5K | 113.0K | +60% | $0 |
| D | 2022-10-31 | 2022-06-15 | MCRB | Arkowitz David | CFO | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-06-15 | M | A | 5,000 | $0.00 | 70,492 | D | — | — | |
| 2 | Common | Common stock | 2022-10-27 | A | A | 42,500 | $0.00 | 112,992 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-06-15 | M | D | 5,000 | $0.00 | 0 | D | — · — to — | 5,000 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) On June 1, 2021, the reporting person was granted an award of restricted stock units, 100% of which vested and settled on June 15, 2022. |